Our findings are clinically relevant, as VEGF, CXCL1, and CXCL16 mRNA expression is associated with OSM and/or OSMR levels in breast cancer patients and with decreased overall survival (Figure 8, E and F). The gene discussed is CXCL16; the disease is breast cancer.